Journal: bioRxiv
Article Title: The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response
doi: 10.64898/2026.01.30.702603
Figure Lengend Snippet: (a) (Top) Schematic representation of 53BP1 F6 fragment sequence, highlighting the OD and the GAR motif. (Bottom) Sequence alignment of the GAR motif region of 53BP1 orthologs from Saccharomyces cerevisiae (RAD9), Caenorhabditis elegans (hsr-9), Schizosaccharomyces pombe (crb2), Danio rerio , Xenopus tropicalis , Homo sapiens , Mus musculus , and Rattus norvegicus . (b) EMSA showing a titration of WT, R→A, R→K F6 fragments against a fixed concentration of 63-nt synthetic ssRNA (1 µM). Quantification was performed by calculating the ratio of bound RNA band intensity over total lane intensity for each condition. Data are presented as mean ± SD from n = 3 independent experiments. Statistical analysis was performed using two-way ANOVA, followed by Dunnett’s post hoc test against “F6 WT” group at each concentration (** P < 0.01, **** P < 0.0001). (C) Representative images of WT, R→A, R→K F6 droplets formation in presence of increasing amounts of RNA, with their relative quantification of droplets number per field and mean droplet area. Data are presented as mean ± SEM from n = 3 independent experiments. Each data point represents the mean of multiple fields from a single replicate. Statistical analysis was performed using two-way ANOVA, followed by Dunnett’s post hoc test against “F6 WT” group at each concentration (*** P < 0.001, **** P < 0.0001). DIC channel is shown; scale bar = 10 µm. (d) EMSA showing a titration of WT, R→K, R→A GAR peptides against a fixed concentration of 63-nt synthetic ssRNA (2 µM). Quantification was performed by calculating the ratio of bound RNA band intensity over total lane intensity for each condition. Data are presented as mean ± SD from n = 3 independent experiments. Statistical analysis was performed using two-way ANOVA, followed by Dunnett’s post hoc test against “GAR WT” group art each concentration (** P < 0.01, **** P < 0.0001). Two-way ANOVA revealed a significant main effect of the protein variant (**** P < 0.0001) and RNA concentration (* P < 0.05), but no significant interaction between the two factors, indicating that the effect of protein variant on droplet formation was consistent across all RNA concentrations tested. (e) Binding curves between 21-nt ssRNA and WT, R→A, R→K GAR peptides, obtained by FP. Polarization values were plotted against peptide concentration, while RNA concentration was kept constant (50 nM). Data are presented as mean ± SD from n = 4 independent experiments. The data points were fitted by non-linear regression using a one-site specific binding model. The solid line represents the best-fit curve. The apparent dissociation constants (K d ) and maximum binding capacities (B max ) are listed in the table (± SEM; n.d. = not determinable under tested conditions). (f) (Left) Phase separation assay showing a titration of WT, R→A, R→K GAR peptides against RNA (1000 ng). The experiment was performed 4 times, with similar results. DIC channel is shown; scale bar = 10 µm. (Right) Graph showing peptide concentrations categorized as positive (filled circle) or negative (open circle) for aggregate-like structures, with half-and-half circles indicating variability in the presence of aggregate structures at that peptide concentration.
Article Snippet: For the expression of 53BP1 fragments as recombinant proteins, 53BP1 fragments were amplified from the plasmid encoding FL 53BP1 (pcDNA5-FRT/TO-eGFP-53BP1, 60813, Addgene) using different primer pairs [FF1/Rev361 for 53BP1 F1 (residues 1-361); FF302/Rev718 for 53BP1 F2 (residues 302-718); FF667/Rev1052 for 53BP1 F3 (residues 667-1052); FF1231/Rev1483 for 53BP1 F6 (residues 1231-1483); FF1053/Rev1711 for 53BP1 F11 (residues 1053-1711); FF1711/Rev1972 for 53BP1 F12 (residues 1711-1972)] and Phusion DNA polymerase (NEB).
Techniques: Sequencing, Titration, Concentration Assay, Quantitative Proteomics, Variant Assay, Binding Assay